|
⚲
|
| Keyboard |
| Martin Heidecker | |
|---|---|
| Firm | |
| Address | c/o Vedanta Biosciences, Inc 19 Blackstone Street Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Elion Therapeutics Inc | 021-516941 | Director | 25.4 M of 83.8 M |
||
| Adaptive Phage Therapeutics Inc | 021-483867 | Director | 12.0 M of 30.0 M |
||
| Vedanta Biosciences Inc | 021-480626 | Director | 118.5 M of 118.5 M |
||
| Venatorx Pharmaceuticals Inc | 021-474330 | Director | 35.0 M of 48.2 M |
||
| Venatorx Pharmaceuticals Inc | 021-457853 | Director | 24.7 M of 24.7 M |
||
| Venatorx Pharmaceuticals Inc | 021-440269 | Director | 34.0 M of 60.0 M |
||
| Rgenta Therapeutics Inc | 021-359879 | Director | 10.0 M of 38.0 M |
||
| Armagen Inc | 021-306863 | Director | 10.0 M of 10.0 M |
||
| Tilos Therapeutics Inc | 021-295149 | Director | 3.0 M of 4.0 M |
||
| Abexxa Biologics Inc | 021-270910 | Director | 1.2 M of 1.7 M |
||
| Tilos Therapeutics Inc | 021-269922 | Director | 0.8 M of 1.5 M |
||
| Sentien Biotechnologies Inc | 021-245621 | Director | 1.0 M of 1.2 M |
||
| Armagen Technologies Inc | 021-187512 | Director | 8.5 M of 17.0 M |
||